Back to search

Article

<u>ST</u>udy of <u>A</u>lteplase for <u>R</u>espiratory Failure in <u>S</u>ARS-CoV-2 COVID-19 (STARS): A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized, Controlled Trial

2021-06-10

Abstract excerpt

Background: Pulmonary vascular microthrombi have been proposed as a mechanism of COVID19 respiratory failure. We hypothesized that early administration of tissue-plasminogen activator(tPA) followed by therapeutic heparin would improve pulmonary function in these patients.<br><br>Methods: Adults with COVID-19-induced respiratory failure were randomized May14, 2020-March 3, 2021 in two phases: Phase-1(n=36): control...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6f753af6-5171-5921-bbde-e9b7b41ce654
DOI
10.2139/ssrn.3859327
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<u>ST</u>udy of <u>A</u>lteplase for <u>R</u>espiratory Failure in <u>S</u>ARS-CoV-2 COVID-19 (STARS): A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized, Controlled TrialDOI 10.2139/ssrn.3859327
Select a neighboring publication to make it the new centre.